High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma

Journal of Clinical Pathology

Volumn 58, Issue 4, 2005, Pages 402-405

  Szladek G ^a,b   Juhasz A ^a   Kardos, K ^a   Szoke K ^a   Major, T ^a   Sziklai, I ^a   Tor, I ^c   Marton I ^c   Konya J ^a   Gergely, L ^a   Szarka, K ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENOTYPE; HUMAN; LARYNX CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PAPILLOMATOSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; SUPERINFECTION; TORQUE TENO VIRUS; WART VIRUS;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; CIRCOVIRIDAE INFECTIONS; DISEASE PROGRESSION; HUMANS; LARYNGEAL NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; TORQUE TENO VIRUS;

EID: 20244381133     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022103     Document Type: Article

References (24)

1. Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
2. zur Hausen H. Papillomavirus infection - a major cause of human cancers. Biochem Biophys Acta 1996;1288:F55-78.
3. dayman GI, Stewart MG, Weber RS, et al. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:743-8.
4. Snijders P, van den Brule A, Meijer C, et al. HPV and cancer of the aerodigestive tract. Papillomavirus Report 1995;6:157-62.
5. Lindeberg H, Krogdahl A. Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 1999;146:9-13.
6. Pintos J, Franco EL, Black MJ, et al. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tracts. Cancer 1999;85:1903-9.
7. Ringström E, Peters E, Hasegawa M, et al. Human papillomavirus type 16 and squamous cell carcinoma or the head and neck. Clin Cancer Res 2002;8:3187-92.
8. Koskinen WJ, Chen RW, Leivo I, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck, Int J Cancer 2003;107:401-6.
9. Sanderson RJ, Ironside JAD. Squamous cell carcinomas of the head and neck. BMJ 2002;325:822-7.
10. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachiomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000;85:35-9.
11. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology or invasive cervical cancer. J Natl Cancer Inst 2002;94:1604-13.
12. Okamoto H, Nishizawa T, Takahashi M, et al. Heterogeneous distribution of TT virus of distinct genotypes in multiple tissues from infected humans. Virology 2001;288:358-68.
13. Maggi F, Marchi S, Fornai C, et al. Relationship of TT virus and Helicobacter pylori infection in gastric tissues of patients with gastritis. J Med Virol 2003;71:160-5.
14. Deng X, Terunuma H, Handema R, et al. Higher prevalence and viral load of TT virus in saliva than in the corresponding serum: another possible route and replication site of TT virus. J Med Virol 1998;56:128-32.
15. Peng YH, Nishizawa T, Takahashi M, et al. Analysis of the entire genome of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch Virol 2002;147:21-41.
16. Okamura A, Yoshioka M, Kubota M, et al. Detection of a novel DNA virus (TTV) sequences in peripheral blood mononuclear cells. J Med Virol 1999;58:174-7.
17. Kónya J, Veress G, Juhász A, et al. Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia. J Clin Microbiol 2000;38:408-11.
18. Okamoto H, Takahashi M, Nishizawa T, et al. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 1999;259:428-36.
19. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
20. Tokita H, Murai S, Kamitsukasa H, et al. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Virol 2002;67:501-9.
21. Garbuglia AR, Iezzi T, Capobianchi MR, et al. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int J Immunopathol Pharmacol 2003;16:109-18.
22. Szladek G, Juhász A, Asztalos L, et al. Persisting TT virus (TTV) genogroup 1 variants in renal transplant recipients. Arch Virol 2003;148:841-51.
23. Takacs M, Balog K, Tóth G, et al. TT virus in Hungary: sequence heterogeneity and mixed infections. FEMS Immun Med Microbiol 2003;35:153-7.
24. Bendinelli M, Pistello M, Maggi F, et al. Molecular properties, biology, and clinical implication of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001;14:98-113.